Bifidobacterium longum and functional GI disorders
AssigneeSociete des Produits Nestle S.A.
InventorsPeter McLean, Gabriela Bergonzelli Degonda, Stephen Michael Collins, Premysl Bercik, Elena Verdu de Bercik
Life of this patent
Estimating the term…
Abstract
The present invention generally relates to the field of probiotic bacteria. In particular, it relates to methods for treating or preventing functional GI disorders comprising administering Bifidobacterium longum, such as Bifidobacterium longum ATCC BAA-999.
Claims13
A method for prevention of an anxiety-linked functional gastrointestinal (GI) disorder, the method comprising administering to a human adult at risk of the functional GI disorder an amount of a composition comprising Bifidobacterium longum ATCC BAA-999 effective to at least partially reduce the risk of developing the functional GI disorder,
- the composition is selected from the group consisting of a dietary supplement, a nutraceutical, a drink, a medical composition, and a powder for reconstitution with a liquid, wherein the composition comprises a fat source that is 20 wt. % to 40 wt. % of the composition, and the composition does not contain any Lactobacillus rhamnosus,
- wherein the anxiety-linked functional GI disorder is selected from the group consisting of irritable bowel syndrome, functional dyspepsia, functional constipation, functional abdominal pain, functional bloating, Epigastric Pain Syndrome, Postprandial Distress Syndrome and combinations thereof, and
- the composition has at least one formulation selected from the group consisting of (i) the composition does not contain inulin and does not contain fructooligosaccharides and (ii) the composition does not contain lactose.
Dependencies are inferred from the claim text.